Imperial College London
Portrait Picture

Dr Charis Pericleous

Faculty of Medicine, National Heart & Lung Institute

Advanced Research Fellow
 
 
 
//

Contact

 

+44 (0)20 7594 2728c.pericleous Website

 
 
//

Location

 

ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{McDonnell:2015,
author = {McDonnell, T and Pericleous, C and Ioannou, Y and Giles, I and Rahman, A},
publisher = {WILEY-BLACKWELL},
title = {Pegylated Recombinant Domain I of Beta-2-Glycoprotein I, a Potential Therapeutic Agent for Antiphospholipid Syndrome, Fully Retains Its Ability to Inhibit Binding of IgG or IgA Antibodies from Patients with APS to Beta-2-Glycoprotein I in Vitro},
url = {https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000370860203583&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb},
year = {2015}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - McDonnell,T
AU  - Pericleous,C
AU  - Ioannou,Y
AU  - Giles,I
AU  - Rahman,A
PB  - WILEY-BLACKWELL
PY  - 2015///
SN  - 2326-5191
TI  - Pegylated Recombinant Domain I of Beta-2-Glycoprotein I, a Potential Therapeutic Agent for Antiphospholipid Syndrome, Fully Retains Its Ability to Inhibit Binding of IgG or IgA Antibodies from Patients with APS to Beta-2-Glycoprotein I in Vitro
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000370860203583&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER  -
Download